September 27, 2017 10:13 AM EDT
Startups

GSK spin­out NeRRe splits the pipeline, cre­ates its own spin­out

Shehla Shakoor

Managing Director

Five years af­ter NeRRe Ther­a­peu­tics spun out of GSK with some of its un­want­ed work in neu­ro­sciences, the UK biotech is ex­e­cut­ing a

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times